Helius Medical Technologies Inc HSDT.OQ HSDT.O is expected to show a fall in quarterly revenue when it reports results on March 26 (estimated) for the period ending December 31 2024
The Newtown Pennsylvania-based company is expected to report a 25.4% decrease in revenue to $100 thousand from $134 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Helius Medical Technologies Inc is for a loss of 94 cents per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated March 24 at 11:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)